<DOC>
	<DOCNO>NCT03063281</DOCNO>
	<brief_summary>Systemic lupus erythematosus ( SLE ) chronic autoimmune disease characterize production multiple autoantibody . The prevalence significance antibody Ficolin-2 yet investigate . The aim study determine prevalence anti-ficolin-2 antibody among SLE patient investigate potential diagnostic and/or prognostic biomarkers SLE . This study secondary phase serum sample analysis do early 2015 order determine prevalence anti-ficolin-2 antibody among cohort previously declare study ( ClinicalTrials.gov ID : NCT02625831 ; Unique Protocol ID : 1841851v0 ) . In retrospective study , clinical data obtain medical file blood sample select preexist biological collection . SLE patient ( n=165 ) inform object , match healthy control ( n=48 ) . Disease activity determine accord SLEDAI score . Anti-ficolin-2 antibody level measure serum ELISA correlate previously obtain Anti-ficolin-3 , Anti-ficolin-2 , anti-dsDNA anti-C1q antibody level . The titer anti-ficolin-2 antibody correlate SLEDAI score ( p &lt; 0.0001 ) . The presence anti-ficolin-2 antibody associate anti-ficolin-3 antibody , anti-C1q anti-dsDNA antibody . Interestingly , combination anti-ficolin-3 , anti-ficolin-2 anti-C1q antibody demonstrate high specificity traditional biomarker . These result suggest anti-ficolin-3 anti-ficolin-2 antibody could useful diagnosis active nephritis SLE patient .</brief_summary>
	<brief_title>Anti-ficolin-2 Autoantibodies Lupus Nephritis</brief_title>
	<detailed_description>For retrospective study , well write brief summary sufficient .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>165 SLE patient Age : â‰¥ 18 year old Patients lupus diagnostic criterion ( ACR1997 ) Pregnant woman Patient know evolutive cancer 48 healthy patient match age sex one several SLE patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ficolin-2</keyword>
	<keyword>anti-ficolin-2 antibody</keyword>
	<keyword>lupus nephritis</keyword>
	<keyword>Lupus Erythematosus , Systemic</keyword>
	<keyword>biomarker</keyword>
	<keyword>ficolin-3</keyword>
	<keyword>anti-ficolin-3 antibody</keyword>
</DOC>